Aerosolized tobramycin in patients with cystic fibrosis.
Ashby
B L
BL
Stern
D H
DH
D000336:Aerosols; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D006801:Humans; D011549:Pseudomonas / Q000187:drug effects; D014031:Tobramycin / Q000494:pharmacology / Q000627:therapeutic use*; D014974:Xanthomonas / Q000187:drug effects
D000336:Aerosols; D014031:Tobramycin